Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 2024Advanced Pharmaceutical BulletinOpen Access

Investigating functional and folding stability of an engineered E. coli L-asparaginase harboring Y176F/S241C mutations

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMahrokh DastmalchiMHMaryam Hamzeh‐MivehroudHRHassan Rezazadeh

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dastmalchi et al. (2024) studied this question.

synapsesocial.com/papers/68e63c0bb6db6435875cd911https://doi.org/10.34172/apb.2024.048
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonclinical Evaluation of Single-Mutant E. coli Asparaginases Obtained by Double-Mutant Deconvolution: Improving Toxicological, Immune and Inflammatory Responses2024 · 1 citations
  2. 2Protein Bioengineering of a Crucial Biopharmaceutical for Acute Lymphoblastic Leukaemia: Improving Toxicogical, Immune and Inflammatory Responses to Asparaginase2024 · 1 citations
  3. 3Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC22972024 · 2 citations
  4. 4<i>In Silico</i>-Driven Engineering of<i>Halomonas elongata</i>L-Asparaginase: Towards Enhanced Proteolytic Resistance in Lymphoblastic Leukemia2024
  5. 5Recombinant expression and preliminary characterization of a synthetic L‐asparaginase from the marine bacterium Pseudoalteromonas tetraodonis GFC in Escherichia coli BL21 (DE3)2026